Arpida AG was a Swiss biopharmaceutical company focused on developing novel anti-infective drugs, notably the antibiotic iclaprim for serious bacterial infections including those…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Arpida AG →Already a subscriber? Sign in
Xcout Intel tracks Arpida AG continuously — this profile deepens as new filings, funding, people and hiring data arrive.